Author

Gadepalli R

Deptt of Microbiology - Cited by 1,411

Biography

Dr.RAVI SEKHAR GADEPALLI received his PhD in Microbiology from All India Institute of Medical Sciences (AIIMS), New Delhi, India. He is currently working as an Associate professor at the Department of Microbiology, All India Institute of Medical Sciences,Jodhpur,India. He have also made significant contributions in the areas of Infectious Diseases. His areas of research includes Clinical and Microbiological Techniques, Biotechnology Techniques,Protein Chemistry,Molecular biology, Animal Practices.  
Title
Cited by
Year
[2Fe-2S] cluster transfer in iron–sulfur protein biogenesis
L Banci, D Brancaccio, S Ciofi-Baffoni, R Del Conte, R Gadepalli, ...Proceedings of the National Academy of Sciences 111 (17), 6203-6208, 2014201
132
2014
Mupirocin resistance in Staphylococcus aureus in an Indian hospital
R Gadepalli, B Dhawan, S Mohanty, A Kapil, BK Das, R Chaudhry, ...Diagnostic microbiology and infectious disease 58 (1), 125-127, 2007200
77
2007
Dissemination of methicillin-resistant Staphylococcus aureus SCCmec type IV and SCCmec type V epidemic clones in a tertiary hospital: challenge to infection control
B Dhawan, C Rao, EE Udo, R Gadepalli, S Vishnubhatla, A KapilEpidemiology & Infection 143 (2), 343-353, 2015201
64
2015
Tigecycline susceptibility report from an Indian tertiary care hospital
B Behera, A Das, P Mathur, A Kapil, R Gadepalli, B DhawanIndian Journal of Medical research 129 (4), 446-450, 2009200
59
2009
The enigma of low COVID-19 fatality rate in India
A Samaddar, R Gadepalli, VL Nag, S MisraFrontiers in Genetics 11, 854, 2020202
49
2020
Clinical and molecular characteristics of nosocomial meticillin-resistant Staphylococcus aureus skin and soft tissue isolates from three Indian hospitals
R Gadepalli, B Dhawan, A Kapil, V Sreenivas, M Jais, R Gaind, ...Journal of Hospital Infection 73 (3), 253-263, 2009200
49
2009
In vitro antimicrobial activity of alpha-melanocyte stimulating hormone against major human pathogen Staphylococcus aureus
T Shireen, SK Venugopal, D Ghosh, R Gadepalli, B Dhawan, ...Peptides 30 (9), 1627-1635, 2009200
43
2009
Nuclear factor of activated T cells c1 mediates p21-activated kinase 1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber …
V Kundumani-Sridharan, NK Singh, S Kumar, R Gadepalli, GN RaoJournal of Biological Chemistry 288 (30), 22150-22162, 2013201
38
2013
Novel role for p21-activated kinase 2 in thrombin-induced monocyte migration
R Gadepalli, S Kotla, MR Heckle, SK Verma, NK Singh, GN RaoJournal of Biological Chemistry 288 (43), 30815-30831, 2013201
37
2013
Epidemiology of Congenital Rubella Syndrome (CRS) in India, 2016-18, based on data from sentinel surveillance
M Murhekar, S Verma, K Singh, A Bavdekar, N Benakappa, S Santhanam, ...PLoS neglected tropical diseases 14 (2), e0007982, 2020202
29
2020
Novel role of proline-rich nonreceptor tyrosine kinase 2 in vascular wall remodeling after balloon injury
R Gadepalli, NK Singh, V Kundumani-Sridharan, MR Heckle, GN RaoArteriosclerosis, thrombosis, and vascular biology 32 (11), 2652-2661, 2012201
24
2012
Decreased susceptibility to vancomycin in meticillin-resistant Staphylococcus aureus: a 5 year study in an Indian tertiary hospital
B Dhawan, R Gadepalli, C Rao, A Kapil, V SreenivasJournal of medical microbiology 59 (3), 375-376, 2010201
23
2010
Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B. 1.617. 2/Delta variant in India, 2021: a multi-centric hospital-based case …
Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B. 1.617. 2/Delta variant in India, 21: a multi-centric hospital-based case …T Bhatnagar, S Chaudhuri, M Ponnaiah, PD Yadav, R Sabarinathan, ...International Journal of Infectious Diseases 122, 693-702, 222
20
2022
Polymorphisms in genes associated with drug resistance of Plasmodium vivax in India.
PS Anantabotla VM, Antony HA, Parija SC, Rajkumari N, Kini JR, Manipura R ...Parasitol Int. 70 (20 Mar 2), 92-97, 202
19
2019
Recent methods for diagnosis of nontuberculous mycobacteria infections: Relevance in clinical practice
KRAS Maurya Anand Kumar, Nag Vijaya Lakshmi, Kant Surya, Sharma Anuradha ...Biomedical and Biotechnology Research Journal (BBRJ) 1 (1), -18, 2017201
14
2017
Molecular diagnosis of COVID-19: an update and review
Molecular diagnosis of COVID-1: an update and reviewK Priyadarshi, VL Nag, SP Kombade, RS Gadepalli, S Misra, K SinghAnnals of the National Academy of Medical Sciences (India) 56 (03), 126-137, 2020202
9
2020
Predictors of Clinical Outcomes in Adult COVID-19 Patients Admitted to a Tertiary Care Hospital in India: an analytical cross-sectional study
MS Chauhan NK, Shadrach BJ, Garg MK, Bhatia P, Bhardwaj P, Gupta MK, Dutt N ...Acta Bio Med 92, 20209202
9
2020
A 5‐year study of dengue seropositivity among suspected cases attending a teaching hospital of North‐Western region of India
JM Kalita, A Aggarwal, K Yedale, R Gadepalli, VL NagJournal of Medical Virology 93 (6), 333-3343, 2021202
8
2021